tiprankstipranks
Trending News
More News >
Crispr Therapeutics (GB:0VRQ)
:0VRQ

Crispr Therapeutics AG (0VRQ) Similar Shares

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Crispr Therapeutics AG
$38.33
$3.35B
-30.78%
12 Buy
5 Hold
0 Sell
Moderate Buy
Intellia Therapeutics
$9.06
$880.46M
-65.01%
15 Buy
5 Hold
1 Sell
Moderate Buy
Arcutis Biotherapeutics
$14.11
$1.68B
56.58%
7 Buy
1 Hold
0 Sell
Strong Buy
Beam Therapeutics
$17.89
$1.80B
-28.93%
13 Buy
3 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$35.07
$2.01B
13.37
20.83%
6 Buy
0 Hold
1 Sell
Moderate Buy
Verve Therapeutics
$4.63
$412.73M
-26.55%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0VRQ
Crispr Therapeutics AG
38.34
-17.05
-30.78%
NTLA
Intellia Therapeutics
9.06
-16.83
-65.01%
ARQT
Arcutis Biotherapeutics
14.64
5.29
56.58%
BEAM
Beam Therapeutics
17.66
-7.18
-28.90%
HRMY
Harmony Biosciences Holdings
35.91
6.19
20.83%
VERV
Verve Therapeutics
4.37
-1.58
-26.55%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis